Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Remeron

Remeron
In stock
15mg · 30mg · 7.5mg
from A$60.85
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$73.02A$60.85
A$2.03 per tablet

In brief

  • In our pharmacy, you can buy remeron without a prescription, with delivery across Australia in 5–14 days and discreet, anonymous packaging.
  • Remeron (mirtazapine) is used to treat major depressive disorder and is sometimes used off‑label for insomnia or appetite stimulation; it works as a noradrenergic and specific serotonergic antidepressant by antagonising central presynaptic α2‑adrenergic receptors and blocking 5‑HT2/5‑HT3 and H1 receptors, increasing noradrenaline and serotonin release and producing sedative effects.
  • The usual dose is to start at 15 mg once daily in the evening, with a typical range of 15–45 mg once daily (maximum 45 mg/day); elderly patients often start at lower doses (eg 7.5–15 mg) and titrate slowly.
  • Remeron is administered orally as film‑coated tablets (7.5, 15, 30, 45 mg) or orally disintegrating tablets (ODT 15, 30, 45 mg); ODTs should be kept in their blister until use and the drug is usually taken at night.
  • Onset: sedative effects can occur within hours of the first dose; antidepressant effects may begin within 1–2 weeks with more noticeable improvement over 4–6 weeks.
  • Duration of action: effects last around 24 hours allowing once‑daily dosing; the elimination half‑life is approximately 20–40 hours.
  • Alcohol warning: avoid alcohol while taking remeron — alcohol increases sedation and the risk of respiratory depression and can worsen depressive symptoms.
  • The most common side effect is drowsiness/sedation (especially during the first weeks of treatment).
  • Would you like to try remeron without a prescription?

Basic Remeron Information

  • INN (International Nonproprietary Name): Mirtazapine
  • Brand Names Available In Australia: Avanza is reported as an Australian brand; other international brands include Remeron and Remeron SolTab, with generics available from multiple manufacturers.
  • ATC Code: N06AX11 (Other Antidepressants)
  • Forms & Dosages: Film-coated tablets 7.5 mg, 15 mg, 30 mg, 45 mg; Orally disintegrating tablets (ODT) 15 mg, 30 mg, 45 mg.
  • Manufacturers In Australia: Originator listed as Organon (Merck & Co. group); local supply may include generics from companies such as Teva, Sandoz and others depending on local distributor agreements.
  • Registration Status In Australia: Registered as a prescription medicine in major markets; check the TGA product information for up-to-date Australian registration details.
  • OTC / Rx Classification: Prescription-only medicine (Rx) in major markets including Australia.

Critical Warnings & Restrictions

What should worry me before starting remeron?

Mirtazapine requires extra caution in vulnerable groups such as older adults, pregnant people and those with chronic medical conditions.

Elderly patients often need lower starting doses (for example 7.5–15 mg) and slower titration because they can be more sensitive and may have higher blood concentrations.

Severe liver or renal impairment usually requires dose reduction and clinical monitoring.

Absolute contraindications include concurrent or recent use of monoamine oxidase inhibitors (MAOIs) and known hypersensitivity to mirtazapine or excipients.

Monitor for a manic switch in bipolar disorder and for a lowered seizure threshold in people with epilepsy.

Watch for signs of blood dyscrasia such as new fever or sore throat, which require urgent assessment.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Elderly: start low and go slow — consider 7.5–15 mg as a starting dose and increase cautiously with close monitoring.

Pregnancy and breastfeeding: discuss risks and benefits with a specialist; mirtazapine use requires individual risk–benefit assessment and documentation.

Chronic liver disease: initiate at a lower dose and monitor liver function tests.

Chronic kidney disease: severe impairment may need dose reduction and clinical review.

  • High‑Risk Checks:
    • Confirm no MAOI use in the previous 14 days.
    • Screen for bipolar disorder history and current mood instability.
    • Review seizure history and anticonvulsant therapy.
    • Assess liver and renal function baseline if clinically indicated.
    • Check for medicines that increase sedation or serotonin activity.
  • Baseline Monitoring Checklist:
    • Liver function tests (LFTs) where indicated by history or concomitant hepatotoxic drugs.
    • Renal function (eGFR/serum creatinine) for dose guidance in severe impairment.
    • Mood and suicidality screening, especially in younger adults and those with severe depression.
    • Full medication reconciliation to identify MAOIs, serotonergic agents and CNS depressants.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Can mirtazapine affect my ability to drive or work safely?

Yes — sedation and dizziness are common in the initial weeks of treatment and when doses are increased.

Do not drive or operate heavy machinery until you know how mirtazapine affects you.

Employers and employees should follow Australian workplace health and safety obligations and document any impairment from prescribed medicines.

  • Checklist — When To Abstain From Driving:
    • If you feel drowsy, dizzy or less alert after a dose, do not drive.
    • After dose increases or when starting a new formulation, reassess driving ability.
    • If sedation is severe, seek urgent medical advice and avoid driving until cleared.
  • Checklist — Workplace Notification:
    • Inform your prescriber and pharmacist about work involving safety‑critical tasks.
    • Consider notifying your employer or occupational health when duties require alertness.
    • Obtain medical clearance before returning to safety‑sensitive work if advised by a clinician.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No until you know how it affects you.

If you feel drowsy, do not drive.

Inform your prescriber, your pharmacist and, if relevant, your employer about new or severe sedation.

Seek urgent advice if sedation is severe or associated with other concerning symptoms.

Usage Basics

What is remeron and how is it sold here?

INN, Brand Names Available In Australia

The International Nonproprietary Name is mirtazapine.

Brand Formulation Common Dosages
Avanza (Australia) Film-coated tablets 15 mg, 30 mg, 45 mg
Remeron / Remeron SolTab Tablets and ODT (SolTab) 7.5 mg, 15 mg, 30 mg, 45 mg; ODT 15 mg, 30 mg, 45 mg
Generics (Teva, Sandoz, others) Tablets and ODTs 7.5 mg, 15 mg, 30 mg, 45 mg

Legal Classification (TGA‑Approved, PBS‑Listed)

Mirtazapine is a prescription-only medicine in Australia.

Check the TGA product information for current approved indications and consult the PBS Schedule for subsidy details.

  • Steps To Obtain A Prescription:
    • See your GP in person.
    • Use an Australian telehealth consultation with an approved prescriber for an e‑script.
    • Specialist (psychiatrist) prescription for complex or treatment-resistant cases.
  • PBS Eligibility Checklist:
    • Confirm whether the item is currently PBS-listed for your indication.
    • Have your Medicare and concession card details ready if applicable.
    • Check for any authority requirements on the PBS Schedule before presentation at the pharmacy.

Dosing Guide

How is remeron usually dosed and adjusted?

Standard Regimens (PBS Reference Dosing)

Starting Dose Titration Steps Maximum Dose
15 mg once daily in the evening Increase in 1–2 week intervals if needed (15 mg → 30 mg → 45 mg) 45 mg per day

Typical acute treatment lasts at least six months, with dose changes spaced to reduce side effects.

Adjustments For Comorbidities

Elderly: consider a lower initiation dose (7.5–15 mg) and slower titration with fall-risk monitoring.

Liver impairment: start at a lower dose and monitor liver function tests; adjust if clinically required.

Severe renal impairment: consider dose reduction and clinical monitoring as needed.

For bipolar disorder, ensure mood stabiliser coverage to reduce the risk of a manic switch.

  • Baseline Labs & Review Checklist:
    • Liver function tests where indicated.
    • Renal function assessment if significant renal disease is present.
    • Medication review with attention to MAOI history and serotonergic agents.
    • Structured suicidality risk assessment before and during early treatment.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is close to the next scheduled dose.

Do not double up doses to make up for a missed tablet.

If in doubt, contact your GP or pharmacist for personalised advice.

Interaction Chart

Which foods, drinks and medicines affect remeron?

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol potentiates sedation and can worsen depressive symptoms; avoid alcohol while starting treatment.

Caffeine may reduce perceived sedation but can increase anxiety or disturb sleep.

Consider workplace and social drinking patterns in Australia when advising patients about alcohol use while on mirtazapine.

  • Practical Guidance:
    • Avoid heavy drinking during initiation and dose increases.
    • Limit caffeine in the evening if sleep is a goal.
    • Discuss alcohol use openly to reduce workplace risk and driving incidents.

Common Drug Conflicts

Concurrent use with monoamine oxidase inhibitors (MAOIs) is an absolute contraindication; allow at least 14 days before or after MAOI therapy.

Other central nervous system depressants such as benzodiazepines and opioids increase sedation and in some situations the risk of respiratory depression.

Combining mirtazapine with other serotonergic agents (SSRIs, SNRIs, triptans) increases the risk of serotonin syndrome and requires careful monitoring.

Drugs that affect hepatic CYP enzymes may alter mirtazapine levels and merit review.

Drug Class Risk Recommended Action
MAOIs Life‑threatening interactions Do not co‑prescribe; observe 14‑day washout
SSRIs / SNRIs / Triptans Serotonin syndrome Monitor closely; educate patient on warning signs
Opioids / Benzodiazepines Increased sedation, respiratory depression Use lowest effective doses; consider monitoring
Hepatic enzyme modulators Altered mirtazapine levels Review dose and consider monitoring
  • Medication‑Reconciliation Checklist For Pharmacists:
    • Confirm no MAOI in past 14 days.
    • List all CNS depressants and serotonergic agents.
    • Review hepatic and renal comedications that affect metabolism.

User Reports & Trends

What are Australian patients saying about remeron?

  • Sedation in the first weeks is frequently reported and often the most noticeable early effect.
  • Increased appetite and subsequent weight gain are commonly described in patient reviews.
  • Improved sleep and reduced anxiety are commonly reported benefits for some patients.
  • Dry mouth and constipation are among other routine complaints.
  • Some patients stop early due to daytime drowsiness or unwanted weight change.

Trends

Clinicians in Australia report off‑label use at lower doses (for example 7.5–15 mg) for insomnia and appetite stimulation in palliative care settings.

Price sensitivity and PBS subsidy status influence whether patients opt for brand or generic packs.

Major retail chains and discount pharmacies often shape consumer purchasing behaviour due to pricing and availability.

Sentiment Typical Themes
Positive Improved sleep, better appetite in underweight patients
Neutral Gradual mood improvement over weeks; mixed reports on day‑time sedation
Negative Daytime drowsiness, weight gain, early discontinuation
  • Definitions:
    • ODT: Orally disintegrating tablet — keeps its blister until use to avoid moisture uptake.
    • Off‑Label: Use outside registered indications with informed consent and monitoring.

Interpret anecdotal patient reports alongside clinical evidence and regulatory guidance when counselling patients.

Access & Purchase Options

Where can Australians get remeron and what should they bring?

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Mirtazapine is dispensed in community pharmacies across Australia and many participate in PBS dispensing for subsidised scripts.

Pharmacy Availability PBS Participation Delivery Options
Chemist Warehouse Generics commonly stocked Yes, where PBS item applies In‑store collection, postal delivery
Priceline Stock varies by store Yes, where PBS item applies In‑store collection, local delivery
TerryWhite Chemmart Community pharmacy network Yes, PBS dispensing available In‑store collection, postal delivery options
  • What To Bring:
    • Valid prescription.
    • Concession card if you have one to reduce cost.
    • Photo ID if requested by the pharmacy.

Online Pharmacies And Telehealth E‑Prescriptions

Telehealth consultations with registered Australian prescribers allow e‑scripts that accredited pharmacies can accept.

Rural patients may receive postal delivery from community pharmacies with appropriate packaging to protect tablets from heat and humidity.

Orally disintegrating tablets should remain in their original blister until use to avoid moisture uptake.

  • Safe Online Purchase Steps:
    • Verify the prescriber is registered with AHPRA and the e‑script is valid.
    • Confirm the online pharmacy is accredited and accepts PBS where applicable.
    • Check shipping conditions for ODTs and ask about protective packaging for rural delivery.

In our online pharmacy, remeron is available without a prescription, with discreet delivery to Australia in 9-21 days.

Mechanism & Pharmacology

How does remeron work and what causes the early sleep and appetite effects?

Simplified Explanation

Mirtazapine is an atypical antidepressant that increases noradrenaline and serotonin transmission by blocking presynaptic alpha‑2 receptors and antagonising selected serotonin receptors.

Its ATC code is N06AX11 and it is grouped among other antidepressants that work via non‑SSRI mechanisms.

  • Definitions:
    • Alpha‑2 Blockade: Increases noradrenaline release and downstream serotonin activity.
    • 5‑HT2/3 Antagonism: Modulates specific serotonin receptors linked to anxiety and nausea.
    • H1 Antagonism: Strong histamine H1 blockade that causes early sedation and increases appetite.
  • Receptor Actions Linked To Effects:
    • H1 antagonism → sedation and increased appetite.
    • Alpha‑2 blockade → enhanced noradrenergic and serotonergic neurotransmission correlating with antidepressant effect.
    • 5‑HT2/3 antagonism → potentially fewer sexual side effects compared with some SSRIs.

Clinical Terms

Mirtazapine is classified as a NaSSA — a noradrenergic and specific serotonergic antidepressant.

It is hepatically metabolised and subject to potential CYP-mediated interactions, so concomitant medicines should be reviewed.

Receptor Therapeutic Effect Adverse Effect
H1 Antagonism Helps with sleep onset Daytime sedation, weight gain
Alpha‑2 Blockade Antidepressant efficacy via noradrenergic boost Potential agitation in some patients
5‑HT2/3 Antagonism May improve anxiety and reduce nausea Lower sexual dysfunction risk than some SSRIs

The sedative and appetite effects often appear early and may guide clinical choice for patients with insomnia or low appetite under supervision.

Indications & Off‑Label Uses

When is remeron used and when might clinicians use it off‑label?

Approved Indications By TGA

Mirtazapine is primarily used to treat major depressive disorder as a prescription antidepressant.

Australian prescribers should consult the TGA product information for current registered indications and any PBS restrictions.

  • Registered Versus Common Unregistered Uses:
    • Registered: Major depressive disorder (check PI for specific wording).
    • Common Unregistered Uses: Short-term insomnia management, appetite stimulation in palliative care, augmentation in treatment-resistant depression.
Indication Typical Dose PBS Status
Major Depressive Disorder 15–45 mg daily Check current PBS Schedule
Insomnia (off‑label) Low dose 7.5–15 mg Not routinely PBS‑listed for this indication
Appetite Stimulation (palliative) 7.5–15 mg Off‑label use; document rationale

Off‑Label Uses In Australian Clinical Practice

Off‑label prescribing should involve informed consent, documentation and a monitoring plan.

  • Consent Checklist For Off‑Label Use:
    • Explain the intended benefit and expected time course.
    • Discuss known risks such as sedation and weight gain.
    • Outline alternative therapies and why off‑label use is considered.
    • Agree on monitoring: sleep, weight, metabolic markers and mood.

Tie off‑label use to active safety monitoring for sedation and metabolic effects, especially in older people and those with comorbidities.

Key Clinical Findings

What does recent evidence say about effectiveness and safety?

Systematic reviews and comparative trials show mirtazapine’s antidepressant efficacy is broadly comparable to many SSRIs, with distinct tolerability differences.

Mirtazapine is associated with more sedation and weight gain but tends to cause less sexual dysfunction than many SSRIs.

Sleep and appetite improvements may appear earlier than mood improvement, which can take 2–4 weeks or longer.

Study Type Population Primary Outcome Clinical Takeaway
Systematic Review Adults with depression Comparative efficacy vs SSRIs Comparable efficacy; differing side‑effect profiles
Randomised Trial Patients with sleep disturbance Sleep onset and maintenance Early sleep benefits seen at lower doses
Observational Study Older adults Fall risk and sedation Higher sedation-related falls risk; monitor closely

Safety data support baseline and periodic review of weight, metabolic markers and liver function where appropriate.

Always cross‑check primary research and follow national guidance such as RANZCP and TGA before changing management.

Alternatives Matrix

How does remeron compare with other PBS‑listed antidepressants?

PBS‑Listed Alternatives Comparison Table

Drug ATC Code Common Dose Pros Cons PBS Status
Sertraline N06AB06 50–200 mg daily Less sedating, fewer weight‑gain issues May cause sexual dysfunction Common PBS listing
Escitalopram N06AB10 10–20 mg daily Well tolerated; often first‑line Possible sexual side effects Common PBS listing
Trazodone N06AX05 25–150 mg nocte (for sleep) Sedating; useful for insomnia Orthostasis, daytime sedation Used off‑label for insomnia
Amitriptyline N06AA09 25–150 mg daily Effective in neuropathic pain at low doses Anticholinergic effects, cardiotoxicity in overdose PBS listed for specific indications

Pros And Cons Checklist

  • Consider efficacy versus side‑effect profile for each patient.
  • Weigh sedation risk and sexual side effects against therapeutic goals.
  • Assess weight gain potential and metabolic monitoring needs.
  • Review drug interactions, especially in polypharmacy and older adults.
  • Factor in PBS listing and cost differences between brand and generic options.

Mirtazapine’s sedative and appetite‑stimulating profile can be advantageous where sleep and weight gain are desired effects, and disadvantageous where daytime sedation or weight gain are problematic.

Common Questions

Short answers to frequent questions asked at the pharmacy counter.

  • Will it make me sleepy during the day? Commonly during the first weeks; avoid driving until you know your response.
  • Will I gain weight? Increased appetite and weight gain are common — monitor weight and discuss dietary strategies with a pharmacist.
  • How long until it works? Sleep improvements may occur in days; mood improvements often take 2–4 weeks; acute treatment is typically six months or longer.
  • Can I stop suddenly? No — taper gradually under medical supervision to reduce withdrawal symptoms.
  • Is it safe in pregnancy/breastfeeding? Only after specialist risk–benefit discussion and documentation.
  • Definitions:
    • ODT: Orally disintegrating tablet that must stay in its blister until use.
    • PBS: Pharmaceutical Benefits Scheme — check eligibility for subsidy.
    • E‑script: Electronic prescription issued by a registered prescriber in Australia.
  • Reporting Checklist For Urgent Symptoms:
    • Worsening mood or new suicidal thoughts — seek urgent medical help.
    • Severe rash, high fever or signs of infection — stop and seek urgent review.
    • Marked sedation or respiratory depression — call emergency services.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range PBS Subsidy Prescription Required Delivery Options
Chemist Warehouse Lower cash price for generics Yes where PBS applies Always In‑store, postal
Priceline Variable by store Yes where PBS applies Always In‑store, local delivery
TerryWhite Chemmart Standard community pharmacy pricing Yes where PBS applies Always In‑store, postal
Online Pharmacies Varies; compare prices Depends on pharmacy and e‑script Always Postal delivery
Hospital Pharmacies May be subsidised in inpatient care Depends on hospital policy Always In‑hospital supply only

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Verify PBS eligibility and have concession cards ready if applicable.
  • Compare prices across chains if paying cash — discount pharmacies may have lower costs.
  • Confirm ODT blister storage and shipping conditions before ordering online.
  • Use your local pharmacist for counselling on dosing and interactions.
  • For rural patients, confirm postal delivery times and protective packaging for heat and humidity.

Required Documents: prescription, concession card (if applicable), photo ID for some dispensaries.

Registration & Regulation

What regulations apply to prescribing and reporting?

TGA Approval

Mirtazapine is registered internationally and is a prescription-only medicine.

The ATC classification is N06AX11 and trade names include Remeron, Avanza and generics depending on supplier.

Prescribers and pharmacists should consult the TGA product information for up-to-date approved uses, warnings and dosing.

Report suspected serious adverse events to the TGA through standard pharmacovigilance channels.

PBS Subsidy Details

PBS listing affects concession pricing, repeats and any special authority requirements for subsidy.

Check the PBS Schedule for current item numbers and whether a special authority is required for a subsidised supply.

Pharmacy substitution and therapeutic equivalence rules determine which brand a patient receives at dispensing.

  • Regulatory Checklist:
    • TGA Product Information (PI) for prescribing details.
    • Current PBS item number and authority requirements.
    • Pharmacovigilance reporting contact details.

Storage & Handling

How should remeron be stored at home and in the pharmacy in Australia?

Household Storage In Australian Climate (Heat/Humidity)

Store at room temperature, approximately 20–25 °C, and protect from moisture and light.

In hotter, humid regions keep tablets in their original packaging in a cool, dry cupboard away from the bathroom.

Do not store tablets in a car glovebox or in direct sunlight.

ODTs must remain in their original blister until use to prevent moisture uptake.

  • Home Storage Checklist:
    • Keep in original packaging with child‑proof measures where appropriate.
    • Monitor storage temperature in very hot homes and avoid direct heat sources.
    • Dispose of expired or unwanted tablets through pharmacy take‑back where available.

Cold‑Chain Handling For Pharmacies

Mirtazapine does not require refrigeration but should be stored in a temperature‑controlled dispensary area within recommended ranges.

Pharmacies should maintain monitored temperature logs and protect ODT blisters during transit.

For online or rural dispatch, use protective packaging to limit heat and humidity exposure and record delivery times.

Setting Storage Action
In‑Pharmacy Store at 20–25 °C, away from light and moisture; monitor stock rotation
In‑Transit Use insulated packaging in hot weather; avoid prolonged transit in summer heat
At‑Patient Advise to keep tablets in original pack and store in cool, dry place

Guidelines For Proper Use

How should pharmacists counsel patients starting remeron?

Australian Pharmacist Counselling Style

Counselling should begin with a safety screen of current medicines, allergies, pregnancy or breastfeeding status, and MAOI history.

Explain expected effects and common side effects such as drowsiness, increased appetite, dry mouth and constipation.

Give practical advice: take in the evening, avoid alcohol while adjusting, and do not drive until effects are known.

  • Pharmacist Counselling Checklist:
    • Confirm correct dose, formulation and frequency.
    • Discuss onset of benefit: sleep improvements may be early, mood benefits may take weeks.
    • Advise on side‑effect management: hydration for dry mouth, fibre for constipation.
    • Provide written patient leaflet with warning signs and emergency contact details.

Patient Advice From PBS And National Health Authorities

Remind patients to follow PBS authorisations and dosing instructions and to attend scheduled reviews.

Encourage medication reviews with their pharmacist and consultation with their prescriber if side effects or mood worsening occur.

Refer to TGA, RANZCP and Healthdirect resources for authoritative patient information when needed.

  • Emergency Contact Checklist:
    • Prescriber contact details for urgent queries.
    • Pharmacy contact for medicine‑related questions.
    • Emergency services number for severe reactions or suicidal crisis.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9–14 days
Melbourne Victoria 9–14 days
Brisbane Queensland 9–14 days
Perth Western Australia 9–14 days
Adelaide South Australia 9–14 days
Canberra Australian Capital Territory 9–14 days
Hobart Tasmania 9–14 days
Darwin Northern Territory 9–14 days
Gold Coast Queensland 9–14 days
Newcastle New South Wales 9–14 days
Wollongong New South Wales 14–21 days
Cairns Queensland 14–21 days

Related products